FIELD: chemical-and-pharmaceutical industry, in particular production of drugs for joint disease treatment.
SUBSTANCE: claimed agent represents lyophilizate containing glucoseamine salt, chondroitin sulfate and trisaminum in specific component ratio.
EFFECT: agent with increased active ingredient content; diffusion of active substance into joint region with increased rate and effectiveness.
2 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR TREATING PATIENTS FOR ARTICULATION DISEASES | 2005 |
|
RU2292203C1 |
STABLE TREATMENT FOR JOINTS DISEASES | 2018 |
|
RU2680804C1 |
REMEDY FOR TREATING DISEASES OF JOINTS | 2005 |
|
RU2275190C1 |
AGENT FOR TREATMENT OF JOINT DISEASES | 2005 |
|
RU2275199C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271812C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271811C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2005 |
|
RU2282437C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
Authors
Dates
2007-01-10—Published
2005-08-16—Filed